Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance

Fig. 2

CRC patient survival is associated with LBX2-AS1 expression levels. A Kaplan–Meier analysis using the online tool GEPIA indicated that patients whose CRC tissues had high LBX2-AS1 expression exhibited significantly reduced overall survival relative to LBX2-AS1-low expressing cases. B Analysis of disease-free survival in the dataset from A showed no significant differences between high and low LBX2-AS1 expressing cases. C Kaplan–Meier analysis of CRC patients from cohort A showing high LBX2-AS1 CRC expression cases exhibited significantly reduced overall survival relative to LBX2-AS1-low expression cases (P = 0.003). D Analysis of disease-free survival in the dataset from C showed no significant differences between high and low LBX2-AS1 expressing cases. For AD, log rank test

Back to article page